Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 22

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

385

HTML

3719

Tables (1-2)

226

Sum=4330

Jun 14, 2007 (publication date) through Feb 9, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jun 14, 2007; 13(22): 3084-3089
Published online Jun 14, 2007. doi: 10.3748/wjg.v13.i22.3084

Table 2 Immunogenicity data of GeneVac-B, Engerix B and Shanvac B in babies born to HBsAg positive mothers

Citation: Velu V, Nandakumar S, Shanmugam S, Jadhav SS, Kulkarni PS, Thyagarajan SP. Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India. World J Gastroenterol 2007; 13(22): 3084-3089
URL: https://www.wjgnet.com/1007-9327/full/v13/i22/3084.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i22.3084